Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 1
2019 3
2020 2
2021 6
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.
Papadimitriou MA, Soureas K, Papanota AM, Tsiakanikas P, Adamopoulos PG, Ntanasis-Stathopoulos I, Malandrakis P, Gavriatopoulou M, Sideris DC, Kastritis E, Avgeris M, Dimopoulos MA, Terpos E, Scorilas A. Papadimitriou MA, et al. Among authors: papanota am. J Transl Med. 2023 Apr 6;21(1):245. doi: 10.1186/s12967-023-04034-5. J Transl Med. 2023. PMID: 37024879 Free PMC article.
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.
Papanota AM, Karousi P, Kontos CK, Artemaki PI, Liacos CI, Papadimitriou MA, Bagratuni T, Eleutherakis-Papaiakovou E, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Scorilas A, Terpos E. Papanota AM, et al. Int J Mol Sci. 2021 Dec 5;22(23):13144. doi: 10.3390/ijms222313144. Int J Mol Sci. 2021. PMID: 34884950 Free PMC article.
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
Papadimitriou MA, Papanota AM, Adamopoulos PG, Pilala KM, Liacos CI, Malandrakis P, Mavrianou-Koutsoukou N, Patseas D, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Terpos E, Scorilas A. Papadimitriou MA, et al. Among authors: papanota am. Br J Cancer. 2022 Jan;126(1):79-90. doi: 10.1038/s41416-021-01602-8. Epub 2021 Oct 30. Br J Cancer. 2022. PMID: 34718359 Free PMC article.
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone.
Kastritis E, Dialoupi I, Gavriatopoulou M, Roussou M, Kanellias N, Fotiou D, Ntanasis-Stathopoulos I, Papadopoulou E, Ziogas DC, Stamatelopoulos K, Manios E, Ntalianis A, Eleutherakis-Papaiakovou E, Papanikolaou A, Migkou M, Papanota AM, Gakiopoulou H, Psimenou E, Tselegkidi MI, Tsitsilonis O, Kostopoulos I, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: papanota am. Blood Adv. 2019 Oct 22;3(20):3002-3009. doi: 10.1182/bloodadvances.2019000147. Blood Adv. 2019. PMID: 31648323 Free PMC article.
Serum inhibin and leptin: Risk factors for pre-eclampsia?
Chrelias G, Makris GM, Papanota AM, Spathis A, Salamalekis G, Sergentanis TN, Rizos D, Karakitsos P, Chrelias C. Chrelias G, et al. Among authors: papanota am. Clin Chim Acta. 2016 Dec 1;463:84-87. doi: 10.1016/j.cca.2016.10.013. Epub 2016 Oct 11. Clin Chim Acta. 2016. PMID: 27737735
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature.
Karousi P, Papanota AM, Artemaki PI, Liacos CI, Patseas D, Mavrianou-Koutsoukou N, Liosi AA, Kalioraki MA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, Kontos CK. Karousi P, et al. Among authors: papanota am. Biomedicines. 2021 Dec 1;9(12):1811. doi: 10.3390/biomedicines9121811. Biomedicines. 2021. PMID: 34944627 Free PMC article.
17 results